Theory of thoughts (ToM), or the capacity to attribute psychological states to oneself and others, is a core factor of social cognition (SC). Even although its significance for social functioning usually, and neurodevelopmental problems (NDDs), specifically, is nicely established, the hyperlinks between ToM and different cognitive features usually are not. Especially the familial underpinnings of such hyperlinks stay unclear.
Using a co-twin management design, we examined N = 311 twins (imply age M = 17.19 years, 47% females) recognized with autism spectrum dysfunction (ASD), consideration-deficit/hyperactivity dysfunction (ADHD), different NDDs, or sometimes growing people. We used the Reading the Mind in the Eyes Test to operationalize ToM, the Fragmented Pictures Test for central coherence (CC), the Tower Test for govt functioning (EF), and the normal capacity index in the Wechsler Intelligence Scales for IQ.
In the linear regressions, weak CC and a decrease IQ have been related to a decreased ToM capacity throughout pairs. Female intercourse and larger age have been robustly related to elevated ToM capacity, whereas EF was not related to ToM. In the inside-pair analyses, the place unmeasured familial confounders are implicitly adjusted, the associations between ToM and different cognitive features, have been attenuated and the affiliation with CC was non-important.
The end result means that familial elements shared by the twins, reminiscent of genetic and shared setting, affect the affiliation between CC, IQ, and ToM. Future research want to incorporate a bigger pattern of monozygotic twins, who’re genetically similar, with the intention to draw extra agency conclusions relating to the affect of familial elements, and to distinguish between shared environmental and genetic results on the associations between cognitive features.
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
Ferric derisomaltose (FDI) is an intravenous (IV) excessive-dose iron formulation authorised in the US for the remedy of iron deficiency anemia in adults who’re illiberal of/have had an unsatisfactory response to oral iron, or who’ve non-dialysis-dependent continual kidney illness (NDD-CKD). FERWON-NEPHRO was a randomized, open-label, multicenter scientific trial evaluating the security and efficacy of a single infusion of FDI 1,000 mg versus as much as 5 doses of iron sucrose (IS) 200 mg (advisable cumulative dose, 1,000 mg) over eight weeks in sufferers with NDD-CKD and iron deficiency anemia. Of 1,525 sufferers included in the security evaluation, 244 (16%) had a historical past of coronary heart failure (HF).
Overall, the price of critical or extreme hypersensitivity reactions was low and didn’t differ between remedy teams. Cardiovascular hostile occasions (AEs) have been reported for 9.4% of sufferers who had HF and 4.2% who didn’t. Time to first cardiovascular AE was longer following administration of FDI in contrast with IS (hazard ratio: 0.59 [95% CI: 0.37, 0.92]; p=0.0185), a distinction that was comparable in sufferers with or with out HF (p=0.908 for interplay).
Patients achieved a sooner hematological response (assessed by adjustments in hemoglobin and ferritin concentrations, and improve in transferrin saturation) with FDI versus IS. In conclusion, in sufferers with NDD-CKD, a single infusion of FDI was secure, nicely tolerated, and was related to fewer cardiovascular AEs and a sooner hematological response, in comparison with a number of doses of IS. These results have been comparable for sufferers with and with out HF.
Further proof for de novo variants in SYNCRIP as the trigger of a neurodevelopmental dysfunction
SYNCRIP encodes for the Synaptotagmin-binding cytoplasmic RNA-interacting protein, concerned in RNA-binding and regulation of a number of mobile pathways. It has been proposed as a candidate gene for neurodevelopmental problems (NDDs) with autism spectrum dysfunction (ASD), mental incapacity (ID), and epilepsy. We ascertained genetic, scientific, and neuroradiological information of three further people with novel de novo SYNCRIP variants.
All people had ID. Autistic options have been noticed in two. One particular person confirmed myoclonic-atonic epilepsy. Neuroradiological options comprised periventricular nodular heterotopia and widening of subarachnoid areas. Two frameshift variants in the extra severely affected people, seemingly end in haploinsufficiency.
The third missense variant lies in the conserved RRM 2 area seemingly affecting RNA-binding. Our findings assist the significance of RRM domains for SYNCRIP performance and counsel genotype-phenotype correlations. Our research supplies additional proof for an SYNCRIP-related NDD characterised by ID and ASD sporadically accompanied by malformations of cortical growth and myoclonic-atonic epilepsy.
Check This One: Rat Tumor Necrosis Factor (TNF) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat Tumor Necrosis Factor (TNF) concentrations in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. Get More Information: abx050220
Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease
Genetics has pushed important discoveries in the area of neurodegenerative illnesses (NDDs). An rising theme in neurodegeneration warrants an pressing and complete replace: that provider standing of early-onset autosomal recessive (AR) illness, sometimes thought-about benign, is related to an elevated threat of a spectrum of late-onset NDDs.
Glucosylceramidase beta (GBA1) gene mutations, liable for the AR lysosomal storage dysfunction Gaucher illness, are a outstanding instance of this precept, having been recognized as an necessary genetic threat issue for Parkinson illness. Genetic analyses have revealed additional examples, notably GRN, TREM2, EIF2AK3, and a number of different LSD and mitochondria perform genes.
Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | 418.8 EUR |
DcR2 ELISA KIT|Human |
|||
| EF009028 | Lifescience Market | 96 Tests | 826.8 EUR |
Recombinant Human DcR2 Protein |
|||
| RP00992 | Abclonal | 10 μg | 186 EUR |
Human DCR2/TNFRSF10D PicoKine ELISA Kit |
|||
| EK2067 | BosterBio | 96 wells | 510 EUR |
|
Description: For quantitative detection of human DCR2/TNFRSF10D in cell culture supernates, serum and plasma (heparin, EDTA, citrate). |
|||
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | 336 EUR |
Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
| STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-SEPT12 Antibody antibody |
|||
| STJ117759 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT3 Antibody antibody |
|||
| STJ118990 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-DDB1 Antibody |
|||
| A00333 | BosterBio | 100uL | 546 EUR |
|
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6777.36 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 663.31 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 896.16 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3672.72 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| 4-AEA465Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
| ELK8071 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
|
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Anti-H4K20me1 Antibody |
|||
| CI1005 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me1 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-H4K20me3 Antibody |
|||
| CI1011 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me3 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-TIP5 Antibody |
|||
| CI1016 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal TIP5 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human, Mouse. |
|||
Anti-H4K8ac Antibody |
|||
| CI1021 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K8ac Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-MYH11 Antibody |
|||
| CI1028 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MYH11 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human. |
|||
Anti-Ski3 Antibody |
|||
| CI1031 | BosterBio | 150ug/50ul | 589.2 EUR |
|
Description: Rabbit Polyclonal Ski3 Antibody. Validated in ChIP, ChIP-qPCR, IF, IHC, WB and tested in Human. |
|||
Anti-Ski8 Antibody |
|||
| CI1032 | BosterBio | 150ug/60ul | 589.2 EUR |
|
Description: Rabbit Polyclonal Ski8 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Drosophila, Human. |
|||
Anti-H4K5,8,12ac Antibody |
|||
| CI1033 | BosterBio | 50ug/66ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5,8,12ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K5,8,12,16ac Antibody |
|||
| CI1035 | BosterBio | 50ug/66ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5,8,12,16ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K5ac Antibody |
|||
| CI1036 | BosterBio | 50ug/28ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K20me1 Antibody |
|||
| CI1039 | BosterBio | 50ug/25ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me1 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-MeCP2 Antibody |
|||
| CI1047 | BosterBio | 50ug/42ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MeCP2 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-H4K20me3 Antibody |
|||
| CI1050 | BosterBio | 50ug/47ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me3 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, Flow Cytometry, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H3K27me3 Antibody |
|||
| CI1056 | BosterBio | 50ug/34ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H3K27me3 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Arabidopsis, Drosophila, Human, Mouse, Rat, Schistosoma, Zebrafish. |
|||
Anti-MBD1 Antibody |
|||
| CI1058 | BosterBio | 50ug/72ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MBD1 Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, WB and tested in Human, Mouse. |
|||
Anti-p53 Antibody |
|||
| CI1060 | BosterBio | 50ug/50ul | 589.2 EUR |
|
Description: Rabbit Polyclonal p53 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, Flow Cytometry, IHC, WB and tested in Human. |
|||
Anti-H4K8ac Antibody |
|||
| CI1066 | BosterBio | 50ug/41ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K8ac Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4pan Antibody |
|||
| CI1069 | BosterBio | 50ug/44ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4pan Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, WB and tested in Human. |
|||
Anti-H2AK5ac Antibody |
|||
| CI1078 | BosterBio | 50ug/ 54ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H2AK5ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human. |
|||
Antibody Anti-cKit |
|||
| CKITACPO | ImmunoStep | 0,1 mg | 379.8 EUR |
anti- LIN28B antibody |
|||
| FNab04785 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN28B |
|||
anti- LIN41 antibody |
|||
| FNab04787 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN41 |
|||
anti- LIN7A antibody |
|||
| FNab04788 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LIN7A |
|||
anti- LIN7B antibody |
|||
| FNab04789 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN7B |
|||
anti- LIN7C antibody |
|||
| FNab04790 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN7C |
|||
anti- LIN9 antibody |
|||
| FNab04791 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIN9 |
|||
anti- LINGO1 antibody |
|||
| FNab04792 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LINGO1 |
|||
anti- LIPA antibody |
|||
| FNab04793 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPA |
|||
anti- LIPC antibody |
|||
| FNab04794 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPC |
|||
anti- LIPH antibody |
|||
| FNab04795 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPH |
|||
anti- LIPI antibody |
|||
| FNab04796 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LIPI |
|||
anti- LITAF antibody |
|||
| FNab04798 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LITAF |
|||
anti- LKB1 antibody |
|||
| FNab04802 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LKB1 |
|||
anti- LMAN1 antibody |
|||
| FNab04803 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMAN1 |
|||
anti- LMBR1L antibody |
|||
| FNab04804 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMBR1L |
|||
anti- LMF1 antibody |
|||
| FNab04805 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMF1 |
|||
anti- LMF2 antibody |
|||
| FNab04806 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMF2 |
|||
anti- LMNB2 antibody |
|||
| FNab04807 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMNB2 |
|||
anti- LMOD1 antibody |
|||
| FNab04808 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMOD1 |
|||
anti- LMOD3 antibody |
|||
| FNab04809 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMOD3 |
|||
anti- LMP2 antibody |
|||
| FNab04810 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMP2 |
|||
anti- LMP7 antibody |
|||
| FNab04811 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMP7 |
|||
anti- LMX1B antibody |
|||
| FNab04812 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMX1B |
|||
anti- LNPEP antibody |
|||
| FNab04813 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LNPEP |
|||
anti- LNX1 antibody |
|||
| FNab04814 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LNX1 |
|||
anti- LOC123688 antibody |
|||
| FNab04815 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOC123688 |
|||
anti- LOC286135 antibody |
|||
| FNab04816 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOC286135 |
|||
anti- LOC55908 antibody |
|||
| FNab04817 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LOC55908 |
|||
anti- LOC84740 antibody |
|||
| FNab04818 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LOC84740 |
|||
anti- LOH12CR1 antibody |
|||
| FNab04819 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LOH12CR1 |
|||
anti- LONP1 antibody |
|||
| FNab04820 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LONP1 |
|||
anti- LONP1 antibody |
|||
| FNab04821 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LONP1 |
|||
anti- Loricrin antibody |
|||
| FNab04822 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against Loricrin |
|||
anti- LOX antibody |
|||
| FNab04823 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOX |
|||
anti- LPAR4 antibody |
|||
| FNab04824 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPAR4 |
|||
anti- LPCAT1 antibody |
|||
| FNab04825 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPCAT1 |
|||
anti- LPCAT1 antibody |
|||
| FNab04826 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPCAT1 |
|||
anti- LPCAT2 antibody |
|||
| FNab04827 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPCAT2 |
|||
anti- LPCAT4 antibody |
|||
| FNab04828 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPCAT4 |
|||
anti- LPHN3 antibody |
|||
| FNab04829 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPHN3 |
|||
anti- LPIN2 antibody |
|||
| FNab04830 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPIN2 |
|||
anti- LPL antibody |
|||
| FNab04831 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPL |
|||
anti- LPO antibody |
|||
| FNab04834 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPO |
|||
anti- LPP antibody |
|||
| FNab04835 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPP |
|||
anti- LPPR2 antibody |
|||
| FNab04836 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPPR2 |
|||
anti- LPXN antibody |
|||
| FNab04837 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPXN |
|||
anti- LRAT antibody |
|||
| FNab04838 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRAT |
|||
anti- LRCH1 antibody |
|||
| FNab04839 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRCH1 |
|||
anti- LRCH2 antibody |
|||
| FNab04840 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRCH2 |
|||
anti- LRCH3 antibody |
|||
| FNab04841 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRCH3 |
|||
anti- LRDD antibody |
|||
| FNab04842 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRDD |
|||
anti- LRG1 antibody |
|||
| FNab04843 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRG1 |
|||
anti- LRMP antibody |
|||
| FNab04844 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRMP |
|||
anti- LRMP antibody |
|||
| FNab04845 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRMP |
|||
anti- LRP2BP antibody |
|||
| FNab04846 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRP2BP |
|||
anti- LRP5 antibody |
|||
| FNab04848 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRP5 |
|||
anti- LRPAP1 antibody |
|||
| FNab04849 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRPAP1 |
|||
anti- LRPPRC antibody |
|||
| FNab04850 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRPPRC |
|||
anti- LRRC1 antibody |
|||
| FNab04852 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC1 |
|||
anti- LRRC10 antibody |
|||
| FNab04853 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC10 |
|||
anti- LRRC18 antibody |
|||
| FNab04854 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC18 |
|||
anti- LRRC20 antibody |
|||
| FNab04855 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC20 |
|||
anti- LRRC29 antibody |
|||
| FNab04856 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRRC29 |
|||
anti- LRRC41 antibody |
|||
| FNab04857 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC41 |
|||
anti- LRRC47 antibody |
|||
| FNab04858 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC47 |
|||
anti- LRRC4C antibody |
|||
| FNab04859 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC4C |
|||
anti- LRRC52 antibody |
|||
| FNab04860 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC52 |
|||
anti- LRRC8C antibody |
|||
| FNab04861 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC8C |
|||
anti- LRRC8D antibody |
|||
| FNab04862 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC8D |
|||
anti- LRRTM1 antibody |
|||
| FNab04863 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRTM1 |
|||
anti- LRRTM2 antibody |
|||
| FNab04864 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRTM2 |
|||
anti- LRRTM4 antibody |
|||
| FNab04865 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRTM4 |
|||
anti- LRSAM1 antibody |
|||
| FNab04866 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRSAM1 |
|||
anti- LRWD1 antibody |
|||
| FNab04867 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRWD1 |
|||
anti- LSAMP antibody |
|||
| FNab04868 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LSAMP |
|||
anti- LSG1 antibody |
|||
| FNab04869 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LSG1 |
|||
anti- LSM1 antibody |
|||
| FNab04870 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LSM1 |
|||
In this Review, we talk about the proof supporting the strikingly distinct allele-dependent scientific phenotypes noticed in carriers of such gene mutations and its affect on the wider area of neurodegeneration.
0